CÉLULAS MADRE Y TERAPIA CELULAR
Centro de Investigación Cooperativa en Biotecnología
Zamudio, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Cooperativa en Biotecnología (6)
2021
-
Therapeutic targeting of fumaryl acetoacetate hydrolase in hereditary tyrosinemia type i
International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-13
2019
-
Hereditary tyrosinemia type I-associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
Journal of Biological Chemistry, Vol. 294, Núm. 35, pp. 13051-13060
2018
-
Repurposing ciclopirox as a pharmacological chaperone in a model of congenital erythropoietic porphyria
Science Translational Medicine, Vol. 10, Núm. 459
2016
-
Stratification and therapeutic potential of PML in metastatic breast cancer
Nature Communications, Vol. 7
2014
-
Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell
Aging, Vol. 6, Núm. 4, pp. 264-280
2012
-
Sp1 transcription factor interaction with accumulated prelamin A impairs adipose lineage differentiation in human mesenchymal stem cells: Essential role of Sp1 in the integrity of lipid vesicles
Stem Cells Translational Medicine, Vol. 1, Núm. 4, pp. 309-321